NXGLW
NEXGEL, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.01
+1.63%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-71.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Dec 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 6,000 | $1.61 |
| Dec 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $1.57 |
| Nov 7, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $2.52 |
| Oct 6, 2025 | Henry Scott Robert · director | Sale | 825 | $2.50 |
| Oct 6, 2025 | Henry Scott Robert · director | Sale | 7,175 | $2.55 |
| Oct 6, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 1,600 | $2.50 |
| Oct 6, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 2,400 | $2.55 |
| Sep 29, 2025 | Henry Scott Robert · director | Sale | 7,697 | $2.36 |
| Aug 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $2.47 |
| Jun 27, 2025 | glassman steven mark · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | glassman steven mark · director | A-Award | 5,000 | $0.00 |
| Jun 27, 2025 | Henry Scott Robert · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | Henry Scott Robert · director | A-Award | 5,000 | $0.00 |
| Jun 27, 2025 | ZELDIS JEROME B · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | Stein John Nachum · director | A-Award | 30,000 | $2.32 |
| Jun 16, 2025 | Henry Scott Robert · director | Sale | 3,000 | $2.57 |
| Jun 11, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 2,000 | $2.33 |
| Jun 6, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 1,000 | $2.29 |
| Jun 2, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 1,000 | $2.22 |
| May 20, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 1,000 | $2.58 |
| May 13, 2025 | Henry Scott Robert · director | Sale | 3,000 | $2.69 |
| Apr 14, 2025 | Henry Scott Robert · director | Sale | 3,000 | $2.61 |
| Apr 2, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $3.01 |
| Mar 11, 2025 | Henry Scott Robert · director | Sale | 3,000 | $2.87 |
| Mar 5, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $3.16 |
| Feb 12, 2025 | glassman steven mark · director | A-Award | 2,500 | $0.00 |
| Feb 12, 2025 | Henry Scott Robert · director | A-Award | 2,500 | $0.00 |
| Feb 12, 2025 | Henry Scott Robert · director | Sale | 3,000 | $3.27 |
| Feb 5, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $3.64 |
| Jan 8, 2025 | Henry Scott Robert · director | Sale | 3,000 | $3.37 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 1Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | Unchanged | 550,000 | May 15, 2026 |
| WARBERG ASSET MANAGEMENT LLC | Unchanged | 146,091 | May 7, 2026 |
| EMPERY ASSET MANAGEMENT, LP | Unchanged | 90,000 | May 8, 2026 |
| CLEAR STREET GROUP INC. | Reduced | 50,614 | May 15, 2026 |
| UBS GROUP AG | Increased | 16,081 | May 5, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| Clear Street Group Inc. | Sold Out | 0 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Sold Out | 0 | May 15, 2026 |
| Empery Asset Management, LP | Sold Out | 0 | May 8, 2026 |
| Warberg Asset Management LLC | Sold Out | 0 | May 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 29, 2025